CloSys Corp. is seeking $2.38 million from the sale of equity, according to documents filed with the Securities and Exchange Commission.
The company, based in New Brighton, Minnesota, already has raised $1.491 million, the documents said.
Founded in 2005 by Chief Scientific Officer Karol Nowakowski, CloSys is developing a clotting technology designed to quickly seal an artery wall after vascular surgery. The company expects to release results from a pivotal clinical trial in the United States by the end of the year.
When Investment Rhymes with Canada
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
CEO Gervaise Wilhelm founded AngioMedics Inc. (now Boston Scientific-owned), FiberOptic Medical Systems Inc. (sold to a European private equity group), publicly traded Optical Sensors Inc., and XRT Corp. (sold to Medtronic). She also is a former chief operating officer of Uromedica Inc.
